Overview

Feasibility of Retinoic Acid Treatment in Emphysema (FORTE)

Status:
Completed
Trial end date:
2004-12-01
Target enrollment:
Participant gender:
Summary
To conduct feasibility studies on the use of retinoids in the treatment of emphysema. Specific objectives are to identify optimal patient populations, retinoids, doses, dosing schedules, routes of administration, and outcome measures preparatory to conducting a larger, controlled, clinical trial on the efficacy of retinoid therapy in the management of emphysema.
Phase:
Phase 2
Details
Lead Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Treatments:
Isotretinoin
Tretinoin